Letter: Antibiotic susceptibility of Shigella in Australia.
D000667:Ampicillin / Q000494:pharmacology* / Q000627:therapeutic use; D001315:Australia; D004405:Dysentery, Bacillary / Q000188:drug therapy; D006801:Humans; D066298:In Vitro Techniques; D009355:Neomycin / Q000494:pharmacology* / Q000627:therapeutic use; D010403:Penicillin Resistance; D012764:Shigella sonnei / Q000187:drug effects*; D013420:Sulfamethoxazole / Q000494:pharmacology* / Q000627:therapeutic use; D014295:Trimethoprim / Q000494:pharmacology* / Q000627:therapeutic use
D000667:Ampicillin; D014295:Trimethoprim; D009355:Neomycin; D013420:Sulfamethoxazole